Bessemer Group’s Outset Medical OM Stock Holding History

Bessemer Group’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,247	Closed	-$204K	–	2237
2023 Q3	$204K	Buy	1,247 +558	+81%	+$132K	﹤0.01%	1027
2023 Q2	$226K	Buy	+689	New	+$210K	﹤0.01%	1016

Other funds holding OM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Bessemer Group's OM Position: Q4 2023 in Review

Bessemer Group sold out of Outset Medical (OM) in Q4 2023, closing a stake of 1,247 shares — an estimated $204K sold.

Bessemer Group first reported a position in OM in Q2 2023 and held it in 2 quarters. The position peaked at $226K in Q2 2023. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

Bessemer Group reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
Bessemer Group sold 1,247 Outset Medical shares in Q4 2023, an estimated $204K.
Bessemer Group first reported a position in Outset Medical in Q2 2023 and held it in 2 quarters.
Bessemer Group's Outset Medical position peaked at $226K in Q2 2023.
140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Bessemer Group's 13F filing for Q4 2023, filed 9 Feb 2024.